Mekinist 2 mg (Trametinib 2 mg per tablet) by Novartis.
Indications: BRAF V600 mutation-positive melanoma (with dabrafenib, incl. adjuvant), NSCLC and anaplastic thyroid cancer.
Administration: Oral: 2 mg once daily, on an empty stomach.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Novartis |
| Active ingredient | Trametinib 2 mg per tablet — MEK1/2 inhibitor. |
| Strength & pack | 30 film-coated tablets. |
| Form | Film-coated tablets |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |